60 related articles for article (PubMed ID: 8546054)
1. Novel approaches to inhibition of gastric acid secretion.
Sachs G; Shin JM; Hunt R
Curr Gastroenterol Rep; 2010 Dec; 12(6):437-47. PubMed ID: 20924727
[TBL] [Abstract][Full Text] [Related]
2. Acid suppression by proton pump inhibitors enhances aquaporin-4 and KCNQ1 expression in gastric fundic parietal cells in mouse.
Matsuzaki J; Suzuki H; Minegishi Y; Sugai E; Tsugawa H; Yasui M; Hibi T
Dig Dis Sci; 2010 Dec; 55(12):3339-48. PubMed ID: 20437101
[TBL] [Abstract][Full Text] [Related]
3. Gastric epithelial cell modality and proton pump inhibitor.
Masaoka T; Suzuki H; Hibi T
J Clin Biochem Nutr; 2008 May; 42(3):191-6. PubMed ID: 18545640
[TBL] [Abstract][Full Text] [Related]
4. Science review: The use of proton pump inhibitors for gastric acid suppression in critical illness.
Brett S
Crit Care; 2005 Feb; 9(1):45-50. PubMed ID: 15693983
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of rabeprazole once daily for acid-related disorders.
Lanza F; Bardhan KD; Perdomo C; Niecestro R; Barth J
Dig Dis Sci; 2001 Mar; 46(3):587-96. PubMed ID: 11318537
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of ebrotidine, ranitidine, omeprazole, lansoprazole, and bismuth citrate against clinical isolates of Helicobacter pylori.
Alarcón T; Domingo D; Sánchez I; Sanz JC; Martínez MJ; López-Brea M
Eur J Clin Microbiol Infect Dis; 1998 Apr; 17(4):275-7. PubMed ID: 9707312
[TBL] [Abstract][Full Text] [Related]
7. Comparative pharmacokinetic/pharmacodynamic analysis of proton pump inhibitors omeprazole, lansoprazole and pantoprazole, in humans.
Katashima M; Yamamoto K; Tokuma Y; Hata T; Sawada Y; Iga T
Eur J Drug Metab Pharmacokinet; 1998; 23(1):19-26. PubMed ID: 9625268
[TBL] [Abstract][Full Text] [Related]
8. Replacement of oral proton pump inhibitors with intravenous pantoprazole to effectively control gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
Metz DC; Forsmark C; Lew EA; Starr JA; Soffer EF; Bochenek W; Pisegna JR
Am J Gastroenterol; 2001 Dec; 96(12):3274-80. PubMed ID: 11774936
[TBL] [Abstract][Full Text] [Related]
9. Correlation between acid secretion and proton pump activity during inhibition by the proton pump inhibitors omeprazole and pantoprazole.
Nishioka K; Nagao T; Urushidani T
Biochem Pharmacol; 1999 Oct; 58(8):1349-59. PubMed ID: 10487539
[TBL] [Abstract][Full Text] [Related]
10. Proton pump inhibitors: new drugs and indications.
Mears JM; Kaplan B
Am Fam Physician; 1996 Jan; 53(1):285-92. PubMed ID: 8546054
[TBL] [Abstract][Full Text] [Related]
11. Lansoprazole: a comprehensive review.
Zimmermann AE; Katona BG
Pharmacotherapy; 1997; 17(2):308-26. PubMed ID: 9085323
[TBL] [Abstract][Full Text] [Related]
12. [Proton pump inhibitors: Pantoprazole].
Takeuchi K; Hase S
Nihon Rinsho; 2002 Feb; 60 Suppl 2():655-60. PubMed ID: 11979865
[No Abstract] [Full Text] [Related]
13. Differences in binding properties of two proton pump inhibitors on the gastric H+,K+-ATPase in vivo.
Shin JM; Sachs G
Biochem Pharmacol; 2004 Dec; 68(11):2117-27. PubMed ID: 15498502
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
